Advocates of the Make America Healthy Again agenda have expressed skepticism over President Donald Trump’s agreement with ...

President Trump's plan drops the price of Ozempic and Wegovy for Americans, with plans for Medicare to cover the popular ...

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

Trump announced new deals with Eli Lilly and Novo Nordisk to lower GLP-1 costs for Medicare, Medicaid, and cash-paying patients.

For years, obesity rates in the US have gone in one direction: up. From the first year it was launched, Gallup’s National ...

Medicare will cover weight-loss drugs under a deal between the Trump administration and drugmakers Eli Lilly and Novo Nordisk ...

Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available ...

A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

Popular GLP-1 drugs like Ozempic will get cheaper in exchange for partial Medicare coverage, opening up new markets for Eli ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.

Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave ...